Akèy › Kansè nan tete › New Jersey › Clifton
Etid klinik pou Kansè nan tete nan Clifton, NJ
12 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Clifton (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Ap rekriteFaz 3
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Ap rekriteFaz 3
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001), Hackensack · 7 mi lwen
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Ap rekriteFaz 3
- Hackensack Univ Medical Center (HUMC) ( Site 0007), Hackensack · 7 mi lwen
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Ap rekriteFaz 3
- John Theurer Ctr-Hackensack UMC, Hackensack · 7 mi lwen
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
Ap rekriteFaz 2
- Hackensack Meridian Health, Hackensack · 7 mi lwen
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Ap rekriteFaz 1/2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi lwen
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Hackensack University Medical Center, Hackensack · 7 mi lwen
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ap rekriteFaz 1
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7 mi lwen
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Ap rekriteFaz 3
- Hackensack University Medical Center, Hackensack · 7 mi lwen
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Ap rekriteFaz 1
- Hackensack University Medical Center, Hackensack · 7 mi lwen
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Ap rekriteEtid obsèvasyon
- John Theurer Cancer Center, Hackensack · 7 mi lwen
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Clifton
- Kansè Poumon ki pa ti selil24 etid
- Kansè (tout kalite)15 etid
- Myelom Miltip14 etid
- Kansè Metastatik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè ovè11 etid
- Kansè poumon10 etid
- Kansè kolorektal8 etid
- Karsinòm selil skuamèz tèt ak kou8 etid
- Kansè Endomèt8 etid
- Ensifizyans kadyak8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.